Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-2pzkn Total loading time: 0 Render date: 2024-04-30T22:20:04.769Z Has data issue: false hasContentIssue false

179 - Statins

from PART IV - DIAGNOSIS AND TREATMENT

Published online by Cambridge University Press:  04 May 2010

James K. Liao
Affiliation:
Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
William C. Aird
Affiliation:
Harvard University, Massachusetts
Get access

Summary

Risk factors for cardiovascular disease, such as cigarette smoking, hypertension, and elevated serum lipid levels impair endothelial function and lead to the development of atherosclerosis. Recent studies suggest that 3-hydroxy-3-methylglutaryl- CoA (HMG-CoA) reductase inhibitors or statins reduce cardiovascular events, in part, by improving endothelial function. Statins reduce plasma cholesterol levels, thereby decreasing the uptake of modified lipoproteins by endothelial cells (ECs). There is increasing evidence, however, that statins may also exert effects beyond cholesterol lowering. Many of these cholesterol-independent or “pleiotropic” vascular effects of statins appear to involve restoring or improving endothelial function by increasing the bioavailability of nitric oxide (NO), promoting re-endothelization, reducing oxidative stress, inhibiting inflammatory responses, and increasing fibrinolysis. Thus, the endothelium-dependent effects of statinsmay contribute to many of the beneficial effects of statin therapy in cardiovascular disease.

STATINS AND ENDOTHELIAL FUNCTION

Statins inhibit an early rate-limiting step in cholesterol biosynthesis (Figure 179.1). This leads to increased hepatic low density lipoprotein (LDL) receptors and enhanced uptake of cholesterol by the liver. Indeed, therapeutic doses of statins potently reduce serum cholesterol levels in humans, and several large clinical trials have demonstrated that inhibition of HMG-CoA reductase by statins markedly decreases the incidence of cardiovascular events in hypercholesterolemic individuals (1,2). Because of the strong association between elevated serum cholesterol levels and coronary atherosclerotic disease, the reduction of serum cholesterol levels by statins has been proposed to be the predominant mechanism underlying the beneficial effects of these drugs. Indeed, acute plasma LDL aphaeresis improves endothelium-dependent vasodilatation (3), suggesting that statins could restore endothelial function, in part, by lowering serum cholesterol levels.

Type
Chapter
Information
Endothelial Biomedicine , pp. 1668 - 1673
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Statins
    • By James K. Liao, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
  • Edited by William C. Aird, Harvard University, Massachusetts
  • Book: Endothelial Biomedicine
  • Online publication: 04 May 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511546198.180
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Statins
    • By James K. Liao, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
  • Edited by William C. Aird, Harvard University, Massachusetts
  • Book: Endothelial Biomedicine
  • Online publication: 04 May 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511546198.180
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Statins
    • By James K. Liao, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
  • Edited by William C. Aird, Harvard University, Massachusetts
  • Book: Endothelial Biomedicine
  • Online publication: 04 May 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511546198.180
Available formats
×